These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4584457)

  • 41. [About the value of adjuvant chemotherapy in advanced cervical cancer. First results of a prospective randomised study (author's transl)].
    Richter P
    Arch Geschwulstforsch; 1982; 52(2):117-22. PubMed ID: 7049112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Experiences with cytostatic combination therapy in hormone-resistant metastasizing breast cancer].
    Brunner KW
    Schweiz Med Wochenschr; 1969 Sep; 99(36):1298-303. PubMed ID: 5351150
    [No Abstract]   [Full Text] [Related]  

  • 43. Vindesine as a single agent and in combination with adriamycin in the treatment of metastatic breast carcinoma.
    Smith IE; Coombes RC; Evans BD; Ford HT; Gazet JC; Gordon C; McKinna JA; Powles TJ
    Eur J Cancer (1965); 1980; Suppl 1():271-3. PubMed ID: 7032939
    [No Abstract]   [Full Text] [Related]  

  • 44. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
    Heuson JC; Paridaens R
    Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007
    [No Abstract]   [Full Text] [Related]  

  • 45. Combination chemotherapy in breast cancer: a randomized study of 4 versus 5 drugs.
    Ramirez G; Klotz J; Strawitz JG; Wilson WL; Cornell GN; Madden RE; Minton JP
    Oncology; 1975; 32(3-4):101-8. PubMed ID: 1221326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemotherapy of skeletal metastases.
    Cadman E; Bertino JR
    Int J Radiat Oncol Biol Phys; 1976; 1(11-12):1211-5. PubMed ID: 62744
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effectiveness of VM 26, mitomycine C and methotrexate in advanced breast cancer refractory to a four drug combination (author's transl)].
    Pouillart P; Palangie T; Jouve M; Garcia-Giralt E; Magdelenat H
    Bull Cancer; 1979; 66(5):485-90. PubMed ID: 554673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alternating cyclical hormonal-cytotoxic combination chemotherapy in postmenopausal patients with breast cancer. An EORTC trial.
    Heuson JC; Sylvester R; Engelsman E
    Eur J Cancer (1965); 1980; Suppl 1():113-7. PubMed ID: 7032920
    [No Abstract]   [Full Text] [Related]  

  • 49. [On the value of a combination of estrogens and alkylating substances in the treatment of a metastasizing breast carcinoma of the female].
    Nowakowski H; Ruhstrat K
    Dtsch Med Wochenschr; 1966 Oct; 91(40):1775-9. PubMed ID: 5922726
    [No Abstract]   [Full Text] [Related]  

  • 50. CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women.
    Salimtschik M; Snel S; Havsteen H; Dombernowsky P; Mouridsen HT
    Cancer Treat Rep; 1980; 64(4-5):635-7. PubMed ID: 7000346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Breast neoplasms. Progress by means of adjuvant chemotherapy?].
    Senn HJ
    MMW Munch Med Wochenschr; 1980 Jan; 122(1):10-5. PubMed ID: 6767909
    [No Abstract]   [Full Text] [Related]  

  • 52. Recent progress in breast cancer management. Combined modality (adjuvant) therapy.
    Cowan K; Lippman M
    Arch Intern Med; 1981 Jul; 141(8):1055-9. PubMed ID: 7018440
    [No Abstract]   [Full Text] [Related]  

  • 53. [Therapy of metastasizing solid tumors with cyclophosphamide, methotrexate, vincristine and 5-fluorouracil].
    Fritsch H; Castor H; Drings P; Moskwa G
    Verh Dtsch Ges Inn Med; 1973; 79():1373-6. PubMed ID: 4790188
    [No Abstract]   [Full Text] [Related]  

  • 54. First, second and third line chemotherapy programs in metastatic breast carcinoma.
    Rizel S; Sulkes A; Gez E; Brufman G; Biran S
    Isr J Med Sci; 1981; 17(9-10):946-53. PubMed ID: 6171542
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination chemotherapy in disseminated solid tumours.
    Klaassen DJ
    Int J Clin Pharmacol; 1974 Jan; 9(1):41-5. PubMed ID: 4593129
    [No Abstract]   [Full Text] [Related]  

  • 56. Sequence for developing optimal combination chemotherapy of metastatic breast cancer.
    Rosner D; Nemoto T
    Eur J Cancer (1965); 1979 Oct; 15(10):1197-201. PubMed ID: 520394
    [No Abstract]   [Full Text] [Related]  

  • 57. [Diagnostic problems raised by tumors of the skull. A propos 2 cases (author's transl)].
    Mendes da Costa P; Jortay A; Noterman J
    Acta Chir Belg; 1974 Sep; 73(5):554-62. PubMed ID: 4440369
    [No Abstract]   [Full Text] [Related]  

  • 58. [Disseminated breast carcinoma. Study of activity of immunotherapy with BCG and duration of the phase of intensive chemotherapy. Results of a randomized trial (author's transl)].
    Pouillart P; Palangie T; Jouve M; Garcia-Giralt E; Magdelenat H; Asselain B
    Bull Cancer; 1981; 68(1):6-18. PubMed ID: 7013868
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Combination of three therapy methods (operation-radiotherapy-chemotherapy) in case of mammary carcinoma with lymph node metastases].
    von Rottkay P; Lössl HJ
    Strahlentherapie; 1982 Aug; 158(8):476-9. PubMed ID: 7135446
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical experiences with a combination therapy of metastasising genital and mammary carcinomas (author's transl)].
    Brachetti A; Leonhardt A; Limburg H; Osswald H; Schmähl D
    MMW Munch Med Wochenschr; 1974 Nov; 116(47):2037-42. PubMed ID: 4216809
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.